Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Security Plus
Multiple Deliverables
Issue: there is an arrangement to deliver multiple products and services
o The first product is
o The second product is
Analysis:
o Revenue recognition criteria will need to be applied separately to A and B
o In order to record revenue separately, need to determine the FV of each
identifiable component of the arrangement
Conclusion
Dunstan Electric
Inventory
Obsolete inventory
o Needs to be backed out of inventory
Royal Design
Deposit (design fee)
Treated as a deposit and deferred
Unearned revenue on projects that proceed should be debited once project revenue
is recognized
Percentage of completion
Appropriate measures e.g. cost of materials or estimated labour hours which better
represents amount of work performed by RDI
Pharmex
Accounted for as Separate transactions or together?
Option 1: Single, non-monetary exchange
o Measured at fair value of assets received if can be reliably measured then
fair value of assets given up
Option 2: Accounting as separate transactions
o Record at FV if can be determined or carrying amount
o Non-exclusive research rights would be considered non-monetary
government grant and recorded at nominal amount (since we cant
determine fair value)
Layaway transaction
Was sale booked prior to date?
HB 3400 revenue recognized when performance is complete
Client did not commit to a sale and had not signed an agreement obligating purchase
of items at later date
o Therefore no risk of goods has transferred and risk of ownership still lies
with SSL
Deposit amount is the liability which is correct accounting treatment
Disputed accounts payable
Dispute was resolved and liability was established at $80,000 at date of August 25
Settlement is a subsequent event that provides evidence of conditions that existed
AT financial statement date financial statements properly adjusted to reflect this
information
Allowance for Doubtful Accounts
Bankruptcy announced September 4 did not occur until after sale date August 10
Announcement after audit completion date of August 31 BUT financial statements
have not been approved yet
Amount is material and impact on results should be disclosed in notes as
subsequent event
BioVentures
Revenue Recognition Licensing
Separately identifiable components?
o HB 3400.11
o Without hour of consultation, ZP could not development technology and
benefit from initial licensing fees
o BV continues to be involved with technology through R&D makes it hard to
measure FV of components individually
o Two transactions deal with together
Recognition
o Currently immediately recognizes
o BV must provide consulting services over two year period 500 hours
o Upfront fee and milestone payment should be deferred and revenue
recognized based on measure of progress toward completion based on actual
hours provided
Lawsuit
HB 3290 Contingencies
2.5 million gain needs to be reserved as it is a contingent gain
If determined likely that lawsuit will be won and BV will be awarded with damage,
disclosure of gain in notes would be appropriate